We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition

    SF3B1 mutations frequently occur in cancer yet lack targeted therapies. Clinical trials of XPO1 inhibitors, selinexor and eltanexor, in high-risk...

    Sana Chaudhry, Felipe Beckedorff, ... Justin Taylor in Leukemia
    Article Open access 13 July 2024
  2. Dietary salt promotes cognitive impairment through repression of SIRT3/PINK1-mediated mitophagy and fission

    Dietary salt is increasingly recognized as an independent risk factor for cognitive impairment. However, the exact mechanisms are not yet fully...

    Haixia Fan, Minghao Yuan, ... Zhiyou Cai in Molecular and Cellular Biochemistry
    Article 13 July 2024
  3. Analysis of Oncology and Radiation Therapy Representation on the National Board of Medical Examiners Official Practice Material for the United States National Standardized Medical Board Examinations

    Radiation therapy (RT) is a critical component of multidisciplinary cancer care, but has inconsistent curricular exposure. We characterize the...

    Mary T. Mahoney, Lauren C. Linkowski, ... Malcolm D. Mattes in Journal of Cancer Education
    Article Open access 13 July 2024
  4. Deep learning model based on endoscopic images predicting treatment response in locally advanced rectal cancer undergo neoadjuvant chemoradiotherapy: a multicenter study

    Purpose

    Neoadjuvant chemoradiotherapy has been the standard practice for patients with locally advanced rectal cancer. However, the treatment response...

    Junhao Zhang, Ruiqing Liu, ... Yun Lu in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  5. Physiological and cellular mechanisms of ischemic preconditioning microRNAs-mediated in underlying of ischemia/reperfusion injury in different organs

    Ischemia–reperfusion (I/R) injury, as a pathological phenomenon, takes place when blood supply to an organ is disrupted and then aggravated during...

    Izadpanah Gheitasi, Ghaidafeh Akbari, Feryal Savari in Molecular and Cellular Biochemistry
    Article 13 July 2024
  6. Key genes and molecular mechanisms related to Paclitaxel Resistance

    Paclitaxel is commonly used to treat breast, ovarian, lung, esophageal, gastric, pancreatic cancer, and neck cancer cells. Cancer recurrence is...

    Adel I. Alalawy in Cancer Cell International
    Article Open access 13 July 2024
  7. Carbon-ion radiotherapy alone vs. standard dose photon radiation with carbon-ion radiotherapy boost for high-grade gliomas: a retrospective study

    Background

    This study aimed to compare the survival outcome and side effects in patients with primary high-grade glioma (HGG) who received carbon ion...

    **aoJun Li, YanShan Zhang, ... Faxin Wen in BMC Cancer
    Article Open access 13 July 2024
  8. Lnc PVT1 facilitates TGF-β1-induced human cardiac fibroblast activation in vitro and ISO-induced myocardial fibrosis in vivo through regulating MYC

    Cardiac fibrosis is a commonly seen pathophysiological process in various cardiovascular disorders, such as coronary heart disorder, hypertension,...

    Juan Wang, Zhong-Yin Lv, ... Di-Fei Shen in Molecular and Cellular Biochemistry
    Article 13 July 2024
  9. Investigating distinct clinical features and constructing a nomogram model for survival probability in adults with cerebellar high-grade gliomas

    Background

    The clinical features of cerebellar high-grade gliomas (cHGGs) in adults have not been thoroughly explored. This large-scale,...

    Tao Chang, Rui Zhang, ... Qing Mao in BMC Cancer
    Article Open access 13 July 2024
  10. Rare tumours of the pancreas: monocentric study

    Purpose

    The biology of rare pancreatic tumours, which differs from that of ductal pancreatic cancer, requires increased attention. Although the...

    Astrid Bauschke, Annelore Altendorf-Hofmann, ... Utz Settmacher in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  11. Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients

    Variations in pharmacokinetic responses to high-dose methotrexate are essential for the prognosis and management of toxicity in the treatment of...

    Siti Utami Rahmayanti, Riezki Amalia, Taofik Rusdiana in Cancer Chemotherapy and Pharmacology
    Article 13 July 2024
  12. Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study

    Background

    The National Comprehensive Cancer Network (NCCN) guideline recommends consideration of weekly cisplatin as an alternative option for...

    Jas Virk, Jasmin Gill, ... Anurag K. Singh in BMC Cancer
    Article Open access 13 July 2024
  13. Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma

    Background & aims

    Patients with intrahepatic cholangiocarcinoma (iCCA) respond poorly to immune checkpoint blockades (ICBs). In this study, we aimed...

    Bao-Ye Sun, Dai Zhang, ... Shuang-Jian Qiu in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  14. Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study

    Background

    We previously demonstrated the applicability of the concept of “platinum sensitivity” in recurrent endometrial cancer. Although immune...

    Shoji Nagao, Shin Nishio, ... Hisashi Masuyama in International Journal of Clinical Oncology
    Article Open access 13 July 2024
  15. Ferroptosis – a potential feature underlying neratinib-induced colonic epithelial injury

    Purpose

    Neratinib, a small-molecule tyrosine kinase inhibitor (TKI) that irreversibly binds to human epidermal growth factor receptors 1, 2 and 4...

    Triet P. M. Nguyen, Susan L. Woods, ... Joanne M. Bowen in Cancer Chemotherapy and Pharmacology
    Article Open access 13 July 2024
  16. The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosis

    Background

    Gastric cancer (GC) is a deadly disease with poor overall survival and limited therapeutic options. Genetic alterations such as mutations...

    Menghan Fang, Youfen Lin, ... **njian Lin in British Journal of Cancer
    Article 13 July 2024
  17. LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway

    Purpose

    Long noncoding RNAs (lncRNAs) exert a significant influence on various cancer-related processes through their intricate interactions with...

    Baoyang Luo, Lin Zhuang, ... Haisheng Fang in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  18. Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment

    Purpose

    In several Asian countries, hepatocellular carcinoma (HCC) is a leading cause of cancer deaths. HCC risk factors in Asia differ from those...

    Rosmawati Mohamed, Wendy Wang, ... Chee-Kiat Tan in Journal of Gastrointestinal Cancer
    Article Open access 12 July 2024
  19. eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma

    Purpose

    Extracellular heat shock protein 90 AA1(eHSP90α) is intricately linked to tumor progression and prognosis. This study aimed to investigate the...

    Yingzhen Bian, Haizhou Liu, ... Litu Zhang in BMC Cancer
    Article Open access 12 July 2024
Did you find what you were looking for? Share feedback.